No abstract available
MeSH terms
-
Action Potentials
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents / adverse effects*
-
Female
-
Humans
-
Melanoma / drug therapy
-
Middle Aged
-
Muscle, Skeletal / drug effects
-
Muscle, Skeletal / physiopathology
-
Polyradiculoneuropathy / chemically induced*
-
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
pembrolizumab